Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000277229 is annotated as a "novel transcript" mapping to a region within the introns of the LIPC gene but on the sense strand. It is described as a long non-coding RNA (lncRNA) or an uncharacterized RNA gene. There is currently no evidence that this transcript produces a functional protein or acts as a therapeutic target, receptor, enzyme, or other druggable molecule. No aliases, biological functions, or disease associations are known. Its inclusion as a therapeutic target is likely incorrect as it lacks any established or inferred pharmacological relevance.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel transcript, sense intronic to LIPC (ENSG00000277229).